Synthesis of a new class of HIV-1 inhibitors

被引：0

作者：

Farese-Di Giorgio, A

Pairot, S

Patino, N

Condom, R ^{[1
]}

Di Giorgio, C

Aumelas, A

Aubertin, AM

Guedj, R

机构：

[1] Univ Nice, Chim Bioorgan Lab, CNRS ESA 6001, F-06108 Nice 2, France

[2] Fac Pharm Montpellier, CNRS UMR C9955, Ctr Biochim Struct, F-34060 Montpellier, France

[3] Inst Virol, INSERM U74, F-67000 Strasbourg, France

来源：

NUCLEOSIDES & NUCLEOTIDES | 1999年 / 18卷 / 02期

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A new family of molecules potentially inhibitors of the HIV-1 Tat-TAR complex was prepared. These compounds are constituted by dinucleotide analogs (PNA dimer) bound, through a linker, to an arginine residue. In this series, several molecules inhibit viral development in cell culture with a micromolar IC50 and without cellular toxicity until 200 mu M concentration.

引用

页码：263 / 275

页数：13

共 50 条

[41] A NEW HYDROXYETHYLAMINE CLASS OF HIV-1 PROTEASE INHIBITORS WITH HIGH ANTIVIRAL POTENCY AND ORAL BIOAVAILABILITY
KIM, BM
VACCA, JP
GUARE, JP
HANIFIN, CM
MICHELSON, SR
DARKE, PL
ZUGAY, JA
EMINI, EA
SCHLEIF, W
LIN, JH
CHEN, IW
VASTAG, K
OSTOVIC, D
ANDERSON, PS
HUFF, JR
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (19) : 2273 - 2278
[42] Design of new inhibitors of HIV-1 aspartic protease
Miertus, S
Furlan, M
Tossi, A
Romeo, D
CHEMICAL PHYSICS, 1996, 204 (2-3) : 173 - 180
[43] New approach for testing inhibitors of HIV-1 uncoating
Dostalkova, A.
Hadravova, R.
Krizova, I.
Kaufman, F.
Ruml, T.
Rumlova, M.
FEBS OPEN BIO, 2018, 8 : 91 - 91
[44] Design and synthesis of new inhibitors of HIV-1 protease dimerization with conformationally constrained templates
Song, MC
Rajesh, S
Hayashi, Y
Kiso, Y
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (18) : 2465 - 2468
[45] Synthesis of new uracil non-nucleoside derivatives as potential inhibitors of HIV-1
El-Essawy, FA
El-Brollosy, NR
Pedersen, EB
Nielsen, C
JOURNAL OF HETEROCYCLIC CHEMISTRY, 2003, 40 (02) : 213 - 217
[46] SPECIFIC HIV-1 INHIBITORS TARGETED AT THE HIV-1 RT
DECLERCQ, E
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (06): : 673 - 673
[47] The LEDGINs: first-in-class allosteric HIV-1 integrase inhibitors
Desimmie, B.
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2012, 17 : 14 - 14
[48] Design, Synthesis, and X-ray Crystallographic Analysis of a Novel Class of HIV-1 Protease Inhibitors
Ganguly, Ashit K.
Alluri, Sesha S.
Caroccia, Danielle
Biswas, Dipshikha
Wang, Chih-Hung
Kang, Eunhee
Zhang, Yong
McPhail, Andrew T.
Carroll, Steven S.
Burlein, Christine
Munshi, Vandna
Orth, Peter
Strickland, Corey
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (20) : 7176 - 7183
[49] Design, synthesis, and X-ray crystallographic analysis of a novel class of HIV-1 protease inhibitors
Alluri, Sesha
Ganguly, A. K.
Caroccia, Danielle
Biswas, Dipshikha
Wang, Chih-Hung
Kang, Eunhee
Zhang, Yong
McPhail, Andrew T.
Carroll, Steven S.
Burlein, Christine
Munshi, Vandna
Orth, Peter
Strickland, Corey
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
[50] An Isoquinoline Scaffold as a Novel Class of Allosteric HIV-1 Integrase Inhibitors
Wilson, Tyler A.
Koneru, Pratibha C.
Rebensburg, Stephanie V.
Lindenberger, Jared J.
Kobe, Matthew J.
Cockroft, Nicholas T.
Adu-Arnpratwum, Daniel
Larue, Ross C.
Kvaratskhelia, Mamuka
Fuchs, James R.
ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (02): : 215 - 220

← 1 2 3 4 5 →